Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vivus Shares Fall 13 Percent After FDA Topamax Risk Warning
Vivus Shares Fall 13 Percent After FDA Topamax Risk Warning
Vivus Shares Fall 13 Percent After FDA Topamax Risk Warning
Submitted by
admin
on March 4, 2011 - 10:40am
Source:
Bloomberg
News Tags:
Vivus
birth defects
Topamax
JNJ
Qnexa
Headline:
Vivus Shares Fall 13 Percent After FDA Topamax Risk Warning
Do Not Allow Advertisers to Use My Personal information
